IDEXX LABORATORIES INC /DE Deferred Costs, Current
IDEXX LABORATORIES INC /DE (IDXX) had Deferred Costs, Current of $80.05 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredCostsCurrent · last filed 2026-08-04
- 2026-06-30: Deferred Costs, Current $80.05M.
- 2026-03-31: Deferred Costs, Current $76.86M.
- 2025-12-31: Deferred Costs, Current $73.56M.
- 2025-09-30: Deferred Costs, Current $70.01M.
| Period end | Deferred Costs, Current |
|---|---|
| 2026-06-30 | $80.05M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $76.86M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $73.56M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $70.01M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $66.69M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $62.21M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $61.65M 10-K · filed 2026-02-20 |
| 2024-09-30 | $58.51M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $59.63M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $54.49M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $54.08M 10-K · filed 2025-02-21 |
| 2023-09-30 | $52.91M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $52.46M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $50.88M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $50.78M 10-K · filed 2024-02-22 |
| 2022-09-30 | $49.83M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $49.66M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $48.63M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $48.94M 10-K · filed 2023-02-16 |
| 2021-09-30 | $48.16M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $46.98M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $45.26M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $43.75M 10-K · filed 2022-02-16 |
| 2020-09-30 | $42.91M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $41.57M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $39.72M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $39.33M 10-K · filed 2021-02-12 |
| 2019-09-30 | $37.75M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $36.29M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $35.49M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $34.52M 10-K · filed 2020-02-14 |
| 2018-09-30 | $32.77M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $32.30M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $30.35M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $23.52M 10-K · filed 2019-02-15 |
| 2017-09-30 | $22.16M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $20.87M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $19.36M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $18.09M 10-K · filed 2018-02-16 |
| 2016-09-30 | $17.20M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $16.79M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $16.57M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $16.41M 10-K · filed 2017-02-17 |
| 2015-09-30 | $15.68M 10-Q · filed 2015-10-28 |
| 2015-06-30 | $14.23M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $12.75M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $11.26M 10-K · filed 2016-02-17 |
| 2013-12-31 | $8.10M 10-K · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |